Introduction
Valsartan, with the NDC code 51660-142, is a generic angiotensin II receptor antagonist used primarily to treat high blood pressure and heart failure. It is distributed by Ohm Laboratories Inc. and has been on the market since July 7, 2014[1].
Market Context
The pharmaceutical market, particularly for generic drugs like Valsartan, is influenced by several key factors:
Generic Competition
Generic drugs, including Valsartan, face significant competition from other generic manufacturers. This competition often leads to pricing pressures, as multiple suppliers can drive down prices to capture market share[3].
Patent Cliff and Exclusivity
The biopharma industry is facing a substantial loss of exclusivity due to expiring patents on high-revenue products. This trend is expected to continue, with over $300 billion in sales at risk through 2030. However, for Valsartan, the patent has already expired, and it is now a generic drug[3].
Regulatory Environment
Regulatory processes and pricing policies can significantly impact the market for generic drugs. In 2025, life sciences executives expect pricing and access to drugs to be a major issue, affecting their strategies significantly[3].
Market Size and Growth
The global market for generic therapeutic drugs, including angiotensin II receptor antagonists like Valsartan, is expected to grow substantially.
Global Generic Drug Market
The global generic drug market is projected to continue its growth trajectory. For instance, the global market for biologic therapeutic drugs, which includes some generic biologics, is expected to grow from $452.9 billion in 2023 to $823.4 billion by 2028, at a CAGR of 12.7%[4].
Specific Market for Angiotensin II Receptor Antagonists
While specific growth projections for Valsartan are not available, the market for angiotensin II receptor antagonists is generally stable due to the chronic nature of the conditions they treat, such as hypertension and heart failure.
Pricing Dynamics
Pricing for generic drugs like Valsartan is highly competitive and influenced by several factors:
Competitive Pricing
The presence of multiple generic manufacturers leads to competitive pricing. Prices for generic drugs tend to decrease over time as more manufacturers enter the market[3].
Regulatory and Reimbursement Policies
Policies related to drug pricing and reimbursement can significantly impact the market. For example, changes in Medicaid or Medicare reimbursement rates can affect the pricing strategy for generic drugs[3].
Price Projections
Given the competitive nature of the generic drug market and the regulatory environment, here are some insights into price projections:
Current Pricing
As of recent data, the pricing for Valsartan and similar generic drugs is relatively stable but subject to periodic adjustments based on market conditions and regulatory changes.
Future Trends
- Competition: With more generic manufacturers entering the market, prices are likely to remain competitive or decrease slightly over time.
- Regulatory Impact: Any changes in regulatory policies or reimbursement rates could affect pricing. However, given the established nature of Valsartan in the market, significant price fluctuations are less likely.
- Market Demand: The demand for hypertension and heart failure treatments is consistent, which helps maintain a stable market for Valsartan.
Key Takeaways
- Market Stability: The market for Valsartan is expected to remain stable due to consistent demand for hypertension and heart failure treatments.
- Competitive Pricing: Prices will likely remain competitive due to the presence of multiple generic manufacturers.
- Regulatory Influence: Pricing will be influenced by regulatory and reimbursement policies, but significant changes are less likely given the established market position of Valsartan.
FAQs
Q: What is the primary use of Valsartan?
A: Valsartan is primarily used to treat high blood pressure and heart failure.
Q: Who distributes Valsartan with the NDC code 51660-142?
A: Valsartan with the NDC code 51660-142 is distributed by Ohm Laboratories Inc.
Q: How long has Valsartan been on the market?
A: Valsartan has been on the market since July 7, 2014.
Q: What are the key factors influencing the pricing of Valsartan?
A: The pricing of Valsartan is influenced by competition from other generic manufacturers, regulatory policies, and reimbursement rates.
Q: Is the market for Valsartan expected to grow?
A: While the specific market for Valsartan may not grow dramatically, the overall market for generic therapeutic drugs is expected to continue growing.
Sources
- FDA.report: NDC 51660-142 Oral Tablet, Film Coated VALSARTAN.
- Missouri Department of Social Services: MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023.
- Deloitte Insights: 2025 life sciences outlook.
- BCC Research: Biologic Therapeutic Drugs: Technologies and Global Markets.
